Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults

BackgroundPosition emission tomography (PET) imaging using [18F]-setoperone to quantify cortical 5-HT2A receptors has the potential to inform pharmacological treatments for geriatric depression and dementia. Prior reports indicate a significant normal aging effect on serotonin 5HT2A receptor (5HT2AR) binding potential. The purpose of this study was to assess the test-retest variability of [18F]-setoperone PET with a high resolution scanner (HRRT) for measuring 5HT2AR availability in subjects greater than 60 years old. Methods: Six healthy subjects (age range = 65–78 years) completed two [18F]-setoperone PET scans on two separate occasions 5–16 weeks apart.ResultsThe average difference in the binding potential (BPND) as measured on the two occasions in the frontal and temporal cortical regions ranged between 2 and 12%, with the lowest intraclass correlation coefficient in anterior cingulate regions.ConclusionWe conclude that the test-retest variability of [18F]-setoperone PET in elderly subjects is comparable to that of [18F]-setoperone and other 5HT2AR radiotracers in younger subject samples.

[1]  Shitij Kapur,et al.  Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. , 2007, The American journal of psychiatry.

[2]  Marie-Laure Paillère-Martinot,et al.  No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET , 1998, Schizophrenia Research.

[3]  Donald Sashin,et al.  Test–retest variability of serotonin 5‐HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain , 1998, Synapse.

[4]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Alan A. Wilson,et al.  The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. , 2001, The American journal of psychiatry.

[6]  S. Kapur,et al.  Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects. , 1999, The American journal of psychiatry.

[7]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[8]  C Crouzel,et al.  Ligands and tracers for PET studies of the 5-HT system--current status. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[9]  J. Korf,et al.  Imaging of the 5-HT2A system: age-, gender-, and Alzheimer’s disease-related findings , 2003, Neurobiology of Aging.

[10]  J. John Mann,et al.  Higher Postmortem Prefrontal 5-HT2A Receptor Binding Correlates with Lifetime Aggression in Suicide , 2006, Biological Psychiatry.

[11]  B. Pollock,et al.  Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease , 2007, Neuropsychiatric disease and treatment.

[12]  Shitij Kapur,et al.  A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia , 2000, Psychiatry Research: Neuroimaging.

[13]  Rajiv Tandon,et al.  Safety and Tolerability: How Do Newer Generation “Atypical” Antipsychotics Compare? , 2004, Psychiatric Quarterly.

[14]  V. Arango,et al.  Alterations in Monoamine Receptors in the Brain of Suicide Victims , 1992, Journal of clinical psychopharmacology.

[15]  S. Kapur,et al.  Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging. , 1997, Nuclear medicine communications.

[16]  E. Corruble,et al.  Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors , 1997, Psychopharmacology.

[17]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[18]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[19]  R. Kessler,et al.  Analysis of emission tomographic scan data: limitations imposed by resolution and background. , 1984, Journal of computer assisted tomography.

[20]  C Crouzel,et al.  Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone. , 1993, Brain : a journal of neurology.

[21]  B. Mulsant,et al.  PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. , 1999, The American journal of psychiatry.

[22]  Abraham Z Snyder,et al.  Greater loss of 5-HT(2A) receptors in midlife than in late life. , 2002, The American journal of psychiatry.

[23]  Gwenn S. Smith,et al.  Analyses of [18F]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humans , 2001, Synapse.

[24]  P F Liddle,et al.  Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone. , 2000, The American journal of psychiatry.

[25]  N. Alpert,et al.  Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. , 1996, The Journal of pharmacology and experimental therapeutics.

[26]  Shitij Kapur,et al.  An automated method for the extraction of regional data from PET images , 2006, Psychiatry Research: Neuroimaging.

[27]  W. Maier,et al.  5-HT2A receptor density is decreased in the at-risk mental state , 2007, Psychopharmacology.

[28]  Guido F. Schauer,et al.  Neuroanatomical correlates of behavioural disorders in dementia. , 2005, Brain : a journal of neurology.

[29]  Jalpa A Doshi,et al.  The quality of antipsychotic drug prescribing in nursing homes. , 2005, Archives of internal medicine.

[30]  Robert B. Innis,et al.  Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and [18F]deuteroaltanserin , 2001, Psychiatry Research: Neuroimaging.

[31]  Sati Mazumdar,et al.  A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[32]  Y. Samson,et al.  Post-stroke changes in cortical 5-HT2 serotonergic receptors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  I. Ferrier,et al.  5HT2 receptor changes in major depression , 1990, Biological Psychiatry.

[34]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[35]  Shitij Kapur,et al.  Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET , 2001, Neuropsychopharmacology.

[36]  Charles F. Reynolds,et al.  Reduced binding of [ 18 F ]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction , 1998, Brain Research.

[37]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[38]  Alan A. Wilson,et al.  Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD , 1987, Synapse.

[39]  C Crouzel,et al.  Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[40]  C Crouzel,et al.  [18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo. , 1988, European journal of pharmacology.